Scientific article
Review
French

Quelle surveillance médicale des adolescents sous antipsychotiques de deuxième génération ?

Published in

Revue médicale suisse, vol. 10, no. 434, p. 1302,1304-1307

Publication date

2014

Abstract

Since the introduction of so called second generation antipsychotic (SGA), the prescription of these drugs has been relatively frequent in adolescence. This article gives a synopsis of the potential side effects and contra-indications, and proposes a practical guideline for the follow-up of these SGAs in adolescent and young adults. The main secondary side effects are in metabolic, endocrine, neurologic, cardiovascular systems and also on the hematological and liver functions. Thus, a strict follow-up should start before the introduction of a SGA treatment and should be continued during the time of administration. Since there is no common consent for a follow-up in SGA use in adolescents for Europe, this article may give a practical guideline for general practitioners and pediatricians, including a clinical exam and biological parameters to be controlled.

Keywords

  • Adolescent
  • Antipsychotic Agents/adverse effects/contraindications/therapeutic use
  • Anxiety Disorders/drug therapy
  • Humans
  • Hypertension/chemically induced
  • Male
  • Product Surveillance, Postmarketing/methods
  • Weight Gain/drug effects
  • Young Adult

Citation (ISO format)

HUBER-GIESEKE, Tina, PERIN MINISINI, Maria Iole, NARRING, Françoise. Quelle surveillance médicale des adolescents sous antipsychotiques de deuxième génération ? In: Revue médicale suisse, 2014, vol. 10, n° 434, p. 1302,1304–1307.

Main files (1)

Article (Published version)

Identifiers

Journal ISSN

1660-9379
587views
3downloads

Technical informations

Creation

18/03/2015 14:55:00

First validation

18/03/2015 14:55:00

Update

14/03/2023 23:07:29

Status update

14/03/2023 23:07:29

Last indexation

30/10/2024 23:46:31
All rights reserved by Archive ouverte UNIGE and the University of Geneva
OpenAIRE Indexed & Validated